May 15 - 17, 2025 Brasilia - Brazil

Breast Cancer Masterclass – Guests only

Ana Carolina Salles (BRA)

Coordinator

Leandro Gonçalves Oliveira (BRA)

Coordinator

PART 1
8 am – 10 am

Ana Carolina Salles (BRA)

Moderator

Deidimar Cassia Batista Abreu (BRA)

Moderator

Leonardo Santos (BRA)

Moderator

Lucimara Priscila Campos Veras Giorgi (BRA)

Moderator

8 am – 8:20 am
Opening

Peter Barry (UK/Australia) - recorded class

8:20 am – 8:40 am
Breast cancer screening in Brazil - How are we doing?

Marcelo Antonini (BRA)

8:40 am – 9 am
Genetic counseling for all breast cancer patients?

Renata Lazari Sandoval (BRA)

9 am – 9:20 am
The importance of breast MRI in the diagnosis of breast cancer

Daniela Gusmão de Araujo Batista (BRA)

9:20 am – 9:40 am
The role of sentinel lymph nodes in breast cancer treatment

Mauro Pinto Passos (BRA)

9:40 am – 10 am
Discussion

Mauro Pinto Passos (BRA)

10 am – 10:30 am
Coffee Break

Mauro Pinto Passos (BRA)

PART 2
10:30 am – 12:30 pm

Ana Carolina Salles (BRA)

Moderator

Augusto Ribeiro Gabriel (BRA)

Moderator

Cristiane Nimir (BRA)

Moderator

Leandro Gonçalves Oliveira (BRA)

Moderator

10:30 am – 10:50 am
Important aspects and challenges in assessing HER-2 status in 2025

Thiago David Alves Pinto (BRA)

10:50 am – 11:10 am
Neoadjuvant therapy in patients diagnosed with triple negative breast cancer - The state of the art

Fabricio Brenelli (BRA)

11:10 am – 11:30 am
Sequencing treatment of metastatic luminal disease

Romualdo Barroso de Sousa (BRA)

11:30 am – 11:50 am
Treatment sequencing of metastatic triple negative disease

Victor Domingos Lisita Rosa (BRA)

11:50 am – 12:10 pm
Treatment sequencing of metastatic HER2-positive disease

Cristiano Augusto Andrade de Resende (BRA)

12:10 pm – 12:30 pm
Discussion

Rodrigo Pepe (BRA)

12:30 pm – 2 pm
Lunch

Rodrigo Pepe (BRA)

PART 3
2 pm – 4 pm

Karimi Amaral (BRA)

Moderator

Leandro Gonçalves Oliveira (BRA)

Moderator

Nilceana Maya Aires Freitas (BRA)

Moderator

2 pm – 2:20 pm The role of genomic signatures, Oncotype and Mammaprint in the treatment of RH-positive breast cancer, localized disease

Daniel Meirelles Barbalho (BRA)

2:20 pm – 2:40 pm
Adjuvant hormone therapy and the role of cyclin inhibitors in localized/locally advanced breast disease

Ana Carolina Salles (BRA)

2:40 pm – 3 pm
Advances in breast radiotherapy and the impact on breast cancer treatment

Daniel Meirelles Barbalho (BRA)

3 pm – 3:20 pm
Discussion

Daniel Meirelles Barbalho (BRA)

3:20 pm – 4 pm
Coffee Break

Daniel Meirelles Barbalho (BRA)

PART 4
4 pm – 5:30 pm

Pollyana Dornelas Pereira (BRA)

Moderator

Rodrigo Pepe Costa (BRA)

Moderator

4 pm – 4:20 pm
Clinical case discussion - Surgical approach

Leonardo Ribeiro Soares (BRA)

4:20 pm – 4:40 pm
Clinical case discussion - Focus on early disease

Danielle Laperche dos Santos (BRA)

4:40 pm – 5 pm
Clinical case discussion - Metastatic focus

Leandro Gonçalves Oliveira (BRA)

5 pm – 5:30 pm
Closing

Leandro Gonçalves Oliveira (BRA)

Schedule subject to change.

plugins premium WordPress